A 52-year-old man with bipolar disorder has been on lithium 900 mg daily for 3 years with good therapeutic response. He presents with tremor, polyuria, and mild cognitive slowing. His serum lithium level is 0.8 mEq/L (therapeutic range 0.6–1.2 mEq/L). Regarding lithium monitoring and adverse effects, all of the following are correct EXCEPT:

Explanation

## Analysis of Lithium Adverse Effects and Monitoring ### Key Point: **Lithium-induced tremor is dose-dependent and often reversible in early stages, but with chronic exposure (years), fine tremor may persist even after discontinuation.** This is a critical distinction from the statement that tremor will "completely" resolve regardless of duration. ### Correct Answer Rationale Option 3 is **incorrect** because while tremor is indeed dose-dependent and may improve with dose reduction or discontinuation in early phases, **chronic lithium exposure can cause persistent tremor that does not fully resolve even after stopping the drug.** The statement's claim of "complete" resolution "regardless of duration" is false. ### Why Each Correct Option Is True | Feature | Evidence | |---------|----------| | **Nephrogenic DI** | Occurs in 20–40% of chronic users; polyuria/polydipsia are hallmark signs; dose-dependent and may reverse if caught early, but can become irreversible with prolonged exposure | | **Hypothyroidism** | Affects 20–30% of lithium users; TSH screening at baseline and then every 6–12 months is standard practice; lithium inhibits thyroid peroxidase | | **Renal baseline** | Serum creatinine, eGFR, and urinalysis are mandatory before starting lithium to establish baseline renal function and exclude pre-existing kidney disease | ### Clinical Pearl: **High-Yield:** Lithium has a narrow therapeutic window (0.6–1.2 mEq/L). This patient's level is therapeutic, yet he has tremor and polyuria—classic signs of chronic toxicity. The tremor may not fully resolve because of cumulative neurological effects over 3 years. ### Lithium Monitoring Checklist 1. **Baseline:** Renal function (Cr, eGFR), TSH, urinalysis, ECG 2. **Ongoing:** Serum lithium level 5 days after initiation, then every 3–6 months (or after dose change) 3. **Annual:** TSH, renal function, urinalysis 4. **PRN:** If signs of toxicity (coarse tremor, confusion, ataxia, diarrhea) ### Warning: Do not confuse **fine tremor** (dose-dependent, often reversible) with **coarse tremor** (sign of acute toxicity). Chronic fine tremor from long-term lithium use may persist after discontinuation due to neuroadaptation. [cite:Kaplan & Sadock's Synopsis of Psychiatry 11e Ch 31]